Investigational Drug Program

BC Cancer's Investigational Drug Program (IDP) provides fee-for-service preclinical research services and contract manufacturing for academic and private-sector researchers. IDP’s mandate is to help its research partners develop promising therapeutic compounds to the point where they can be tested in early phase human clinical trials.
Back to top